Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Zealand cervical cancer screening project boosted

This article was originally published in Clinica

Executive Summary

Epidemiologists from the University of Auckland have recently joined New Zealand's national audit of invasive cervical cancers. The government's director-general of health, Karen Poutasi, has welcomed the move, saying their expertise will help take forward the project, whose aim is to improve the National Cervical Screening Programme (NCSP). The audit itself can only begin after proposals having been reviewed by a number of ethics committees. "We expect ethics committee approval by early April and the audit will start immediately after that," said Dr Poutasi.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064902

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel